![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com//news-release/2023/10/18/2762183/0/en/Lucy-Scientific-Discovery-s-Alternative-Mental-Health-Treatments-to-Provide-Opportunity-to-Improve-Mental-Health.html
https://www.globenewswire.com//news-release/2023/09/26/2749520/0/en/Lucy-Scientific-Discovery-NASDAQ-LSDI-Acquisitions-Create-Golden-Opportunity-for-Growth-Success.html
https://www.globenewswire.com//news-release/2023/09/20/2746457/0/en/Lucy-Scientific-Discovery-NASDAQ-LSDI-Leverages-Power-of-M-A-to-Capitalize-on-Synergistic-Growth.html
https://www.globenewswire.com//news-release/2023/09/12/2741492/0/en/Lucy-Scientific-Discovery-Inc-Announces-Acquisition-of-BlueSky-Wellness-Inc-in-All-Stock-Transaction.html
https://www.globenewswire.com//news-release/2023/09/08/2740089/0/en/Lucy-Scientific-Discovery-Inc-NASDAQ-LSDI-Acquisition-Strategy-Differentiates-Company-in-Projected-51B-Global-Cannabis-Market.html
https://www.globenewswire.com//news-release/2023/09/07/2739298/0/en/Lucy-Scientific-Acquires-High-Times-Intellectual-Property-Including-Existing-Licensing-Agreements-in-All-Stock-Transaction.html
https://www.globenewswire.com/news-release/2023/07/20/2708212/0/en/Pasithea-Therapeutics-Special-Committee-Rejects-Unsolicited-Bid-from-Lucy-Scientific-Discovery-Inc.html